
### [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907)
**Label:** Uterine Disorder

**Subclasses:** [NCIT:C3662](http://purl.obolibrary.org/obo/NCIT_C3662) (Uterine Polyp), [NCIT:C4630](http://purl.obolibrary.org/obo/NCIT_C4630) (Low Grade Cervical Intraepithelial Neoplasia), [NCIT:C7347](http://purl.obolibrary.org/obo/NCIT_C7347) (Cervical Squamous Cell Carcinoma In Situ), [NCIT:C27815](http://purl.obolibrary.org/obo/NCIT_C27815) (Malignant Endometrial Neoplasm), [NCIT:C7982](http://purl.obolibrary.org/obo/NCIT_C7982) (Cervical Small Cell Carcinoma), [NCIT:C7346](http://purl.obolibrary.org/obo/NCIT_C7346) (Cervical Squamous Intraepithelial Neoplasia), [NCIT:C40229](http://purl.obolibrary.org/obo/NCIT_C40229) (Cervical Adenosarcoma), [NCIT:C3782](http://purl.obolibrary.org/obo/NCIT_C3782) (Cervical Intraepithelial Neoplasia), [NCIT:C40227](http://purl.obolibrary.org/obo/NCIT_C40227) (Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C40228](http://purl.obolibrary.org/obo/NCIT_C40228) (Malignant Cervical Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C40225](http://purl.obolibrary.org/obo/NCIT_C40225) (Cervical Alveolar Soft Part Sarcoma), [NCIT:C40226](http://purl.obolibrary.org/obo/NCIT_C40226) (Cervical Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C40223](http://purl.obolibrary.org/obo/NCIT_C40223) (Uterine Corpus Low Grade Endometrial Stromal Sarcoma), [NCIT:C40224](http://purl.obolibrary.org/obo/NCIT_C40224) (Undifferentiated Endocervical Sarcoma), [NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma), [NCIT:C40222](http://purl.obolibrary.org/obo/NCIT_C40222) (Low Grade Endometrioid Stromal Sarcoma of the Cervix), [NCIT:C34584](http://purl.obolibrary.org/obo/NCIT_C34584) (Endocervical Polyp), [NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma), [NCIT:C40182](http://purl.obolibrary.org/obo/NCIT_C40182) (Uterine Corpus Carcinofibroma), [NCIT:C127058](http://purl.obolibrary.org/obo/NCIT_C127058) (Uterine Corpus Rhabdomyosarcoma), [NCIT:C40181](http://purl.obolibrary.org/obo/NCIT_C40181) (Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C4519](http://purl.obolibrary.org/obo/NCIT_C4519) (Cervical Adenosquamous Carcinoma), [NCIT:C8719](http://purl.obolibrary.org/obo/NCIT_C8719) (Endometrial Squamous Cell Carcinoma), [NCIT:C3434](http://purl.obolibrary.org/obo/NCIT_C3434) (Uterine Corpus Leiomyoma), [NCIT:C128041](http://purl.obolibrary.org/obo/NCIT_C128041) (Cervical Neuroendocrine Neoplasm), [NCIT:C3554](http://purl.obolibrary.org/obo/NCIT_C3554) (Malignant Exocervical Neoplasm), [NCIT:C3553](http://purl.obolibrary.org/obo/NCIT_C3553) (Malignant Endocervical Neoplasm), [NCIT:C3552](http://purl.obolibrary.org/obo/NCIT_C3552) (Malignant Uterine Neoplasm), [NCIT:C7359](http://purl.obolibrary.org/obo/NCIT_C7359) (Endometrial Adenocarcinoma), [NCIT:C4520](http://purl.obolibrary.org/obo/NCIT_C4520) (Cervical Adenocarcinoma In Situ), [NCIT:C3556](http://purl.obolibrary.org/obo/NCIT_C3556) (Malignant Uterine Corpus Neoplasm), [NCIT:C3435](http://purl.obolibrary.org/obo/NCIT_C3435) (Uterine Neoplasm), [NCIT:C40218](http://purl.obolibrary.org/obo/NCIT_C40218) (Endometrioid Stromal and Related Neoplasms of the Cervix), [NCIT:C6300](http://purl.obolibrary.org/obo/NCIT_C6300) (Uterine Corpus Neoplasm), [NCIT:C40219](http://purl.obolibrary.org/obo/NCIT_C40219) (Uterine Corpus Endometrial Stromal Sarcoma), [NCIT:C40216](http://purl.obolibrary.org/obo/NCIT_C40216) (Cervical Soft Tissue Neoplasm), [NCIT:C40217](http://purl.obolibrary.org/obo/NCIT_C40217) (Uterine Corpus Endometrial Stromal and Related Neoplasms), [NCIT:C127907](http://purl.obolibrary.org/obo/NCIT_C127907) (Endocervical Adenocarcinoma, Usual Type), [NCIT:C6385](http://purl.obolibrary.org/obo/NCIT_C6385) (Metastatic Malignant Neoplasm in the Uterine Cervix), [NCIT:C40214](http://purl.obolibrary.org/obo/NCIT_C40214) (Cervical Large Cell Neuroendocrine Carcinoma), [NCIT:C40215](http://purl.obolibrary.org/obo/NCIT_C40215) (Cervical Mullerian Papilloma), [NCIT:C40179](http://purl.obolibrary.org/obo/NCIT_C40179) (Uterine Corpus Soft Tissue Neoplasm), [NCIT:C40210](http://purl.obolibrary.org/obo/NCIT_C40210) (Cervical Glandular Neoplasm), [NCIT:C40177](http://purl.obolibrary.org/obo/NCIT_C40177) (Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential), [NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma), [NCIT:C61574](http://purl.obolibrary.org/obo/NCIT_C61574) (Uterine Corpus Cancer), [NCIT:C40176](http://purl.obolibrary.org/obo/NCIT_C40176) (Uterine Corpus Smooth Muscle Neoplasm), [NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma), [NCIT:C126771](http://purl.obolibrary.org/obo/NCIT_C126771) (Uterine Corpus Neuroendocrine Neoplasm), [NCIT:C39749](http://purl.obolibrary.org/obo/NCIT_C39749) (Type II Endometrial Adenocarcinoma), [NCIT:C126773](http://purl.obolibrary.org/obo/NCIT_C126773) (Uterine Corpus Carcinoid Tumor), [NCIT:C27250](http://purl.obolibrary.org/obo/NCIT_C27250) (Uterine Corpus Adenomatoid Tumor), [NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis), [NCIT:C126772](http://purl.obolibrary.org/obo/NCIT_C126772) (Endometrial Large Cell Neuroendocrine Carcinoma), [NCIT:C113239](http://purl.obolibrary.org/obo/NCIT_C113239) (Uterine Carcinosarcoma, Heterologous Type), [NCIT:C27676](http://purl.obolibrary.org/obo/NCIT_C27676) (Human Papillomavirus-Related Cervical Squamous Cell Carcinoma), [NCIT:C113238](http://purl.obolibrary.org/obo/NCIT_C113238) (Uterine Carcinosarcoma, Homologous Type), [NCIT:C128050](http://purl.obolibrary.org/obo/NCIT_C128050) (Cervical Malignant Peripheral Nerve Sheath Tumor), [NCIT:C27675](http://purl.obolibrary.org/obo/NCIT_C27675) (Human Papillomavirus-Related Cervical Carcinoma), [NCIT:C5385](http://purl.obolibrary.org/obo/NCIT_C5385) (Uterine Angiosarcoma), [NCIT:C8258](http://purl.obolibrary.org/obo/NCIT_C8258) (Stage I Uterine Sarcoma AJCC v7), [NCIT:C8259](http://purl.obolibrary.org/obo/NCIT_C8259) (Stage II Uterine Sarcoma AJCC v7), [NCIT:C27838](http://purl.obolibrary.org/obo/NCIT_C27838) (Endometrial Serous Adenocarcinoma), [NCIT:C27677](http://purl.obolibrary.org/obo/NCIT_C27677) (Human Papillomavirus-Related Endocervical Adenocarcinoma), [NCIT:C127915](http://purl.obolibrary.org/obo/NCIT_C127915) (Cervical Adenocarcinoma Admixed with Neuroendocrine Carcinoma), [NCIT:C42700](http://purl.obolibrary.org/obo/NCIT_C42700) (Uterine Carcinosarcoma), [NCIT:C8261](http://purl.obolibrary.org/obo/NCIT_C8261) (Recurrent Uterine Corpus Sarcoma), [NCIT:C8260](http://purl.obolibrary.org/obo/NCIT_C8260) (Stage III Uterine Sarcoma AJCC v7), [NCIT:C40241](http://purl.obolibrary.org/obo/NCIT_C40241) (Cervical Disorder), [NCIT:C9072](http://purl.obolibrary.org/obo/NCIT_C9072) (Recurrent Uterine Corpus Carcinoma), [NCIT:C27839](http://purl.obolibrary.org/obo/NCIT_C27839) (Endometrial Endometrioid Adenocarcinoma, Secretory Variant), [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder), [NCIT:C128048](http://purl.obolibrary.org/obo/NCIT_C128048) (Cervical Rhabdomyosarcoma), [NCIT:C128049](http://purl.obolibrary.org/obo/NCIT_C128049) (Cervical Angiosarcoma), [NCIT:C128046](http://purl.obolibrary.org/obo/NCIT_C128046) (Cervical Leiomyoma), [NCIT:C128047](http://purl.obolibrary.org/obo/NCIT_C128047) (Cervical Leiomyosarcoma), [NCIT:C128044](http://purl.obolibrary.org/obo/NCIT_C128044) (Cervical Low Grade Neuroendocrine Tumor, Grade 2), [NCIT:C91208](http://purl.obolibrary.org/obo/NCIT_C91208) (Cervical Carcinoma by AJCC v7 Stage), [NCIT:C89551](http://purl.obolibrary.org/obo/NCIT_C89551) (Stage II Cervical Cancer), [NCIT:C89550](http://purl.obolibrary.org/obo/NCIT_C89550) (Stage 0 Cervical Cancer), [NCIT:C128045](http://purl.obolibrary.org/obo/NCIT_C128045) (Cervical Neuroendocrine Carcinoma), [NCIT:C127077](http://purl.obolibrary.org/obo/NCIT_C127077) (Uterine Corpus Germ Cell Tumor), [NCIT:C128043](http://purl.obolibrary.org/obo/NCIT_C128043) (Cervical Low Grade Neuroendocrine Tumor, Grade 1), [NCIT:C3013](http://purl.obolibrary.org/obo/NCIT_C3013) (Endometrial Hyperplasia), [NCIT:C8942](http://purl.obolibrary.org/obo/NCIT_C8942) (Metastatic Endometrial Adenocarcinoma), [NCIT:C7453](http://purl.obolibrary.org/obo/NCIT_C7453) (Exocervical Carcinoma), [NCIT:C8028](http://purl.obolibrary.org/obo/NCIT_C8028) (Endometrial Clear Cell Adenocarcinoma), [NCIT:C8421](http://purl.obolibrary.org/obo/NCIT_C8421) (Cervical Condyloma Acuminatum), [NCIT:C3012](http://purl.obolibrary.org/obo/NCIT_C3012) (Endometrial Neoplasm), [NCIT:C40239](http://purl.obolibrary.org/obo/NCIT_C40239) (Cervical Melanoma), [NCIT:C40236](http://purl.obolibrary.org/obo/NCIT_C40236) (Cervical Wilms Tumor), [NCIT:C27789](http://purl.obolibrary.org/obo/NCIT_C27789) (Endometrial Intraepithelial Neoplasia), [NCIT:C36097](http://purl.obolibrary.org/obo/NCIT_C36097) (Cervical Carcinosarcoma), [NCIT:C40199](http://purl.obolibrary.org/obo/NCIT_C40199) (Cervical Squamous Intraepithelial Neoplasia 1), [NCIT:C36095](http://purl.obolibrary.org/obo/NCIT_C36095) (Cervical Mucinous Adenocarcinoma), [NCIT:C40230](http://purl.obolibrary.org/obo/NCIT_C40230) (Cervical Adenofibroma), [NCIT:C40197](http://purl.obolibrary.org/obo/NCIT_C40197) (High Grade Cervical Squamous Intraepithelial Neoplasia), [NCIT:C40198](http://purl.obolibrary.org/obo/NCIT_C40198) (Cervical Squamous Intraepithelial Neoplasia 2), [NCIT:C40231](http://purl.obolibrary.org/obo/NCIT_C40231) (Cervical Adenomyoma), [NCIT:C40195](http://purl.obolibrary.org/obo/NCIT_C40195) (Cervical Squamous Neoplasm), [NCIT:C127005](http://purl.obolibrary.org/obo/NCIT_C127005) (Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor), [NCIT:C40196](http://purl.obolibrary.org/obo/NCIT_C40196) (Low Grade Cervical Squamous Intraepithelial Neoplasia), [NCIT:C40193](http://purl.obolibrary.org/obo/NCIT_C40193) (Cervical Lymphoepithelioma-Like Carcinoma), [NCIT:C40194](http://purl.obolibrary.org/obo/NCIT_C40194) (Cervical Squamotransitional Carcinoma), [NCIT:C40191](http://purl.obolibrary.org/obo/NCIT_C40191) (Cervical Warty Carcinoma), [NCIT:C40192](http://purl.obolibrary.org/obo/NCIT_C40192) (Cervical Papillary Squamous Cell Carcinoma), [NCIT:C128055](http://purl.obolibrary.org/obo/NCIT_C128055) (Cervical Yolk Sac Tumor), [NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma), [NCIT:C128053](http://purl.obolibrary.org/obo/NCIT_C128053) (Benign Cervical Soft Tissue Neoplasm), [NCIT:C128054](http://purl.obolibrary.org/obo/NCIT_C128054) (Malignant Cervical Soft Tissue Neoplasm), [NCIT:C6856](http://purl.obolibrary.org/obo/NCIT_C6856) (Cervical Microglandular Polyp), [NCIT:C6339](http://purl.obolibrary.org/obo/NCIT_C6339) (Uterine Corpus Sarcoma), [NCIT:C27850](http://purl.obolibrary.org/obo/NCIT_C27850) (Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells), [NCIT:C6336](http://purl.obolibrary.org/obo/NCIT_C6336) (Uterine Corpus Adenosarcoma), [NCIT:C3504](http://purl.obolibrary.org/obo/NCIT_C3504) (Endometrial Disorder), [NCIT:C6335](http://purl.obolibrary.org/obo/NCIT_C6335) (Benign Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C6338](http://purl.obolibrary.org/obo/NCIT_C6338) (Uterine Corpus Adenomyoma), [NCIT:C6337](http://purl.obolibrary.org/obo/NCIT_C6337) (Uterine Corpus Adenofibroma), [NCIT:C6334](http://purl.obolibrary.org/obo/NCIT_C6334) (Metastatic Carcinoma in the Uterine Cervix), [NCIT:C136650](http://purl.obolibrary.org/obo/NCIT_C136650) (Recurrent Cervical Adenosquamous Carcinoma), [NCIT:C136651](http://purl.obolibrary.org/obo/NCIT_C136651) (Recurrent Cervical Adenocarcinoma), [NCIT:C132294](http://purl.obolibrary.org/obo/NCIT_C132294) (Recurrent Endometrial Serous Adenocarcinoma), [NCIT:C40148](http://purl.obolibrary.org/obo/NCIT_C40148) (Grade 3 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40149](http://purl.obolibrary.org/obo/NCIT_C40149) (Grade 1 Endometrial Mucinous Adenocarcinoma), [NCIT:C40146](http://purl.obolibrary.org/obo/NCIT_C40146) (Grade 1 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40147](http://purl.obolibrary.org/obo/NCIT_C40147) (Grade 2 Endometrial Endometrioid Adenocarcinoma), [NCIT:C40144](http://purl.obolibrary.org/obo/NCIT_C40144) (Endometrial Mucinous Adenocarcinoma), [NCIT:C40145](http://purl.obolibrary.org/obo/NCIT_C40145) (Type I Endometrial Adenocarcinoma), [NCIT:C2939](http://purl.obolibrary.org/obo/NCIT_C2939) (Cervical Polyp), [NCIT:C3511](http://purl.obolibrary.org/obo/NCIT_C3511) (Uterine Corpus Degenerated Leiomyoma), [NCIT:C6346](http://purl.obolibrary.org/obo/NCIT_C6346) (Cervical Adenoid Cystic Carcinoma), [NCIT:C7558](http://purl.obolibrary.org/obo/NCIT_C7558) (Endometrial Carcinoma), [NCIT:C2940](http://purl.obolibrary.org/obo/NCIT_C2940) (Cervical Neoplasm), [NCIT:C7674](http://purl.obolibrary.org/obo/NCIT_C7674) (Low Grade Cervical Glandular Intraepithelial Neoplasia), [NCIT:C6343](http://purl.obolibrary.org/obo/NCIT_C6343) (Cervical Endometrioid Adenocarcinoma), [NCIT:C6342](http://purl.obolibrary.org/obo/NCIT_C6342) (Cervical Squamous Papilloma), [NCIT:C27849](http://purl.obolibrary.org/obo/NCIT_C27849) (Oxyphilic Endometrial Endometrioid Adenocarcinoma), [NCIT:C7673](http://purl.obolibrary.org/obo/NCIT_C7673) (Cervical Glandular Intraepithelial Neoplasia), [NCIT:C6345](http://purl.obolibrary.org/obo/NCIT_C6345) (Cervical Undifferentiated Carcinoma), [NCIT:C27846](http://purl.obolibrary.org/obo/NCIT_C27846) (Villoglandular Endometrial Endometrioid Adenocarcinoma), [NCIT:C7675](http://purl.obolibrary.org/obo/NCIT_C7675) (High Grade Cervical Glandular Intraepithelial Neoplasia), [NCIT:C6344](http://purl.obolibrary.org/obo/NCIT_C6344) (Cervical Clear Cell Adenocarcinoma), [NCIT:C7670](http://purl.obolibrary.org/obo/NCIT_C7670) (High Grade Cervical Intraepithelial Neoplasia), [NCIT:C27844](http://purl.obolibrary.org/obo/NCIT_C27844) (Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component), [NCIT:C9179](http://purl.obolibrary.org/obo/NCIT_C9179) (Stage IV Uterine Sarcoma AJCC v7), [NCIT:C27845](http://purl.obolibrary.org/obo/NCIT_C27845) (Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component), [NCIT:C27843](http://purl.obolibrary.org/obo/NCIT_C27843) (Endometrial Endometrioid Adenocarcinoma with Clear Cell Change), [NCIT:C6340](http://purl.obolibrary.org/obo/NCIT_C6340) (Uterine Corpus Leiomyosarcoma), [NCIT:C9180](http://purl.obolibrary.org/obo/NCIT_C9180) (Uterine Corpus Carcinosarcoma), [NCIT:C136649](http://purl.obolibrary.org/obo/NCIT_C136649) (Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified), [NCIT:C7804](http://purl.obolibrary.org/obo/NCIT_C7804) (Recurrent Cervical Carcinoma), [NCIT:C4894](http://purl.obolibrary.org/obo/NCIT_C4894) (Benign Endometrial Neoplasm), [NCIT:C4654](http://purl.obolibrary.org/obo/NCIT_C4654) (Atypical Endometrial Hyperplasia), [NCIT:C8577](http://purl.obolibrary.org/obo/NCIT_C8577) (Infiltrating Cervical Carcinoma), [NCIT:C6433](http://purl.obolibrary.org/obo/NCIT_C6433) (Endometrial Polyp), [NCIT:C6311](http://purl.obolibrary.org/obo/NCIT_C6311) (Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm), [NCIT:C8972](http://purl.obolibrary.org/obo/NCIT_C8972) (Uterine Corpus Undifferentiated Sarcoma), [NCIT:C40208](http://purl.obolibrary.org/obo/NCIT_C40208) (Cervical Villoglandular Adenocarcinoma), [NCIT:C9269](http://purl.obolibrary.org/obo/NCIT_C9269) (Recurrent Malignant Endocervical Neoplasm), [NCIT:C40205](http://purl.obolibrary.org/obo/NCIT_C40205) (Cervical Mucinous Adenocarcinoma, Signet Ring Cell Type), [NCIT:C40206](http://purl.obolibrary.org/obo/NCIT_C40206) (Cervical Mucinous Adenocarcinoma, Minimal Deviation Type), [NCIT:C40203](http://purl.obolibrary.org/obo/NCIT_C40203) (Cervical Mucinous Adenocarcinoma, Intestinal-Type), [NCIT:C28327](http://purl.obolibrary.org/obo/NCIT_C28327) (Endocervical Carcinoma), [NCIT:C40201](http://purl.obolibrary.org/obo/NCIT_C40201) (Cervical Serous Adenocarcinoma), [NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma), [NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma), [NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma), [NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma), [NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma), [NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant), [NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma), [NCIT:C3607](http://purl.obolibrary.org/obo/NCIT_C3607) (Benign Cervical Neoplasm), [NCIT:C3609](http://purl.obolibrary.org/obo/NCIT_C3609) (Benign Uterine Neoplasm), [NCIT:C3608](http://purl.obolibrary.org/obo/NCIT_C3608) (Benign Uterine Corpus Neoplasm), [NCIT:C4029](http://purl.obolibrary.org/obo/NCIT_C4029) (Cervical Adenocarcinoma), [NCIT:C114656](http://purl.obolibrary.org/obo/NCIT_C114656) (Endometrial Adenosquamous Carcinoma), [NCIT:C5356](http://purl.obolibrary.org/obo/NCIT_C5356) (Uterine Corpus Intravenous Leiomyomatosis), [NCIT:C4028](http://purl.obolibrary.org/obo/NCIT_C4028) (Cervical Squamous Cell Carcinoma, Not Otherwise Specified), [NCIT:C9039](http://purl.obolibrary.org/obo/NCIT_C9039) (Cervical Carcinoma), [NCIT:C6287](http://purl.obolibrary.org/obo/NCIT_C6287) (Endometrial Endometrioid Adenocarcinoma), [NCIT:C9311](http://purl.obolibrary.org/obo/NCIT_C9311) (Malignant Cervical Neoplasm), [NCIT:C4262](http://purl.obolibrary.org/obo/NCIT_C4262) (Endometrial Stromal Nodule), [NCIT:C6290](http://purl.obolibrary.org/obo/NCIT_C6290) (Endometrial Endometrioid Adenocarcinoma, Variant with Squamous Differentiation), [NCIT:C126998](http://purl.obolibrary.org/obo/NCIT_C126998) (Uterine Corpus High Grade Endometrial Stromal Sarcoma), [NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma), [NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma), [NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma), [NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma), [NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma), [NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma), [NCIT:C136708](http://purl.obolibrary.org/obo/NCIT_C136708) (Uterine Corpus Sarcoma by AJCC v7 Stage), [NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) 99.74%
- [NCIT:C3435](http://purl.obolibrary.org/obo/NCIT_C3435) (Uterine Neoplasm) 97.93%
- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) and [NCIT:C3674](http://purl.obolibrary.org/obo/NCIT_C3674) (Reproductive System Neoplasm) 97.93%
- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) and [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 97.93%
- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) and [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 97.93%
- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) and [NCIT:C3053](http://purl.obolibrary.org/obo/NCIT_C3053) (Female Reproductive System Neoplasm) 97.93%
- [NCIT:C3435](http://purl.obolibrary.org/obo/NCIT_C3435) (Uterine Neoplasm) and [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) 89.64%
- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) and [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) 89.64%
- [NCIT:C3552](http://purl.obolibrary.org/obo/NCIT_C3552) (Malignant Uterine Neoplasm) 81.35%
- [NCIT:C3435](http://purl.obolibrary.org/obo/NCIT_C3435) (Uterine Neoplasm) and [NCIT:C4913](http://purl.obolibrary.org/obo/NCIT_C4913) (Malignant Female Reproductive System Neoplasm) 81.35%
- [NCIT:C3435](http://purl.obolibrary.org/obo/NCIT_C3435) (Uterine Neoplasm) and [NCIT:C36076](http://purl.obolibrary.org/obo/NCIT_C36076) (Malignant Reproductive System Neoplasm) 81.35%
- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) and [NCIT:C4913](http://purl.obolibrary.org/obo/NCIT_C4913) (Malignant Female Reproductive System Neoplasm) 81.35%
- [NCIT:C26907](http://purl.obolibrary.org/obo/NCIT_C26907) (Uterine Disorder) and [NCIT:C36076](http://purl.obolibrary.org/obo/NCIT_C36076) (Malignant Reproductive System Neoplasm) 81.35%
- [NCIT:C3552](http://purl.obolibrary.org/obo/NCIT_C3552) (Malignant Uterine Neoplasm) and (not ([NCIT:C9364](http://purl.obolibrary.org/obo/NCIT_C9364) (Labia Minora Carcinoma))) 81.35%
- [NCIT:C3552](http://purl.obolibrary.org/obo/NCIT_C3552) (Malignant Uterine Neoplasm) and (not ([NCIT:C9363](http://purl.obolibrary.org/obo/NCIT_C9363) (Labia Majora Carcinoma))) 81.35%


